Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.
about
Diagnosis of lyme borreliosis.Prospective study of serologic tests for lyme disease.Crowded, cell-like environment induces shape changes in aspherical proteinSerologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme testPersistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infectionThe Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American ResearchCurrent Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States.Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera.Identifying diagnostic peptides for lyme disease through epitope discoveryIdentification of Borrelia burgdorferi ribosomal protein L25 by the phage surface display method and evaluation of the protein's value for serodiagnosisIdentification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl.The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease.Emergence of Ixodes scapularis and Borrelia burgdorferi, the Lyme disease vector and agent, in Ohio.Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease.A comparison of serologic tests for the detection of serum antibodies to whole-cell and recombinant Borrelia burgdorferi antigens in cattle.Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States.Survey of selected tick-borne diseases in dogs in Finland.Rapid, simple, quantitative, and highly sensitive antibody detection for lyme diseaseEvaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine.Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigensCharacterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay.Recombinant flagellin A proteins from Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii in serodiagnosis of Lyme borreliosis.Epitope mapping of the immunodominant invariable region of Borrelia burgdorferi VlsE in three host speciesC-terminal invariable domain of VlsE may not serve as target for protective immune response against Borrelia burgdorferi.C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetesImprovement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes.Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndromeOspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients.Laboratory testing for Lyme disease: possibilities and practicalities.Whole Genome Sequence and Comparative Genomics of the Novel Lyme Borreliosis Causing Pathogen, Borrelia mayonii.Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme diseaseA decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease.Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.A prospective study among patients presenting at the general practitioner with a tick bite or erythema migrans in The Netherlands.
P2860
Q22242237-4A5D57CE-7B8B-4307-9B74-4DE5362AD4D9Q22242954-4FC5FB27-F49A-466F-AA16-0C8F9F9F00ADQ24644970-C79609DE-DE09-406C-92A5-0FB7976F6A88Q24678470-5A68441A-E30E-4E8B-A752-C30D1DE00DC5Q27310210-0FD5A611-488F-4F16-AD93-EA7A5D597EF2Q28354112-914B6C08-8F0B-4592-9178-C89A5ED37CF6Q30357899-63F3E0C3-A342-43D2-A5E6-DD902FD61750Q30448319-5422E230-3EB3-42F3-8E8F-9E56E4622DF4Q30977563-44EE54E8-867F-4E45-BEAB-12BAE5244B5FQ33259362-124B921C-BEE9-4E4C-BF70-3EAC082B489DQ33601926-2E3927B4-2CEE-43DB-9C25-096F4D601AAFQ33603169-3079B234-D98F-44A1-8273-21B5CAB112BBQ33627104-DEF62620-5F21-4637-B0B7-294EC681D668Q33708376-19395F9F-BF38-451D-B3D8-2A15C7532E4BQ33711842-D6EAB348-23CA-48B5-A596-BF23EC73324DQ33738269-4CD9267D-D5C3-4ECD-BD88-0260265C11A8Q33777952-E5B0BF4F-4CA9-4A2E-BC82-5C69D2E09C27Q33778130-B7535572-8A17-49A0-A473-1CC2A47B4230Q33816370-9B9397F8-8146-450D-A7D1-7EB629A6CD68Q33819348-E6061C58-59EA-4CA0-86CA-FA75D7A77DA5Q33909157-B91DFE1B-ED00-43F2-955E-5E84CF5B0735Q33962743-DDF6F324-5C5B-4EF5-A345-9E494907FC8BQ33964227-3F4E13AC-E791-46CC-89CD-7AD9260406F9Q33966777-2CB86541-46FF-42D2-9273-4482FFF3DBA4Q33970315-7812C6E5-9D9E-463B-8BCA-357962F7B26AQ33974006-1367088B-B26C-4B71-BB00-0B5E7CC48C69Q34004056-3146A8D2-3AF2-4D47-B3ED-D136B0AE605CQ34006212-60E4104F-CADC-40A2-BB2D-A026289FB43BQ34007344-EB03D367-0925-4381-A12D-2AD890F6EEE8Q34041878-944AC034-4AD3-4070-A2C2-E4F5AE2F15C0Q34045483-61D60F9D-A7B6-47A8-A369-230692DD3421Q34127718-123A25E7-B88F-4A1E-A5EB-939DAB98A9C4Q34202515-3E24F7FC-A00A-4CE3-B923-9BE9EE368061Q34439525-F06428E6-586D-4151-88D5-6C150F7CBBB1Q34515948-3A3FA5A4-F04E-44EF-8866-E3489024C48DQ34548192-E7B81E49-B855-4AAA-95FA-F537AE9187B6Q34568050-207D9B4E-FB6D-446E-8529-43C13C44977EQ34601381-7CDBF70E-701A-412A-B2A5-23A4B41CAEB1Q34701380-17F80107-1955-4A91-BC07-90938F4E7EBCQ34734155-01DFD181-CDD9-42BE-8B00-FAC4F7E2374C
P2860
Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Sensitive and specific serodia ...... of Borrelia burgdorferi vlsE.
@ast
Sensitive and specific serodia ...... of Borrelia burgdorferi vlsE.
@en
type
label
Sensitive and specific serodia ...... of Borrelia burgdorferi vlsE.
@ast
Sensitive and specific serodia ...... of Borrelia burgdorferi vlsE.
@en
prefLabel
Sensitive and specific serodia ...... of Borrelia burgdorferi vlsE.
@ast
Sensitive and specific serodia ...... of Borrelia burgdorferi vlsE.
@en
P2093
P2860
P1476
Sensitive and specific serodia ...... n of Borrelia burgdorferi vlsE
@en
P2093
A C Steere
B J Johnson
J N Miller
M T Philipp
P2860
P304
P407
P577
1999-12-01T00:00:00Z